" class="no-js "lang="en-US"> Cambrian Bio - Medtech Alert
Thursday, March 28, 2024
Cambrian Bio | MTA

Cambrian Bio

About Cambrian Bio

Cambrian Bio
Cambrian Bio is a clinical stage biotechnology company focused on treating and preventing chronic diseases of aging. Cambrian Bio is building therapeutics that increase health span - the period of life spent in good health. As a Distributed Development Company, Cambrian Bio advances multiple scientific breakthroughs, and through this multi-asset approach it attracts top caliber R&D experts as well as experienced business leaders that many single asset early-stage biotech's are unable to access. Cambrian Bio's approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve the overall quality of life during aging. To date, Cambrian Bio has more than a dozen novel therapeutics in its pipeline.

Related Story

Cambrian Bio Appoints Health Policy Veteran Adrienne Hallett as Vice President of Global Policy and Strategic Initiatives

March 20 2023

Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, […]